Plasminogen activator inhibitor 1 and visceral obesity during pronounced weight loss after bariatric surgery.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  NMCD. Nutrition Metabolism and Cardiovascular Diseases

• Publication date

  2012-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.numecd.2010.07.009PMID 21093232
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabolic syndrome, haemostasis and thrombosis

  2008cited by this paper
• Simvastatin Reduces Circulating Plasminogen Activator Inhibitor 1 Activity in Volunteers with the Metabolic Syndrome

  2008cited by this paper
• Multiple Biomarkers and the Risk of Incident Hypertension

  2007cited by this paper
• Human visceral adipose tissue and the plasminogen activator inhibitor type 1

  2007cited by this paper
• Cholesterol suppresses cellular TGF-β responsiveness: implications in atherogenesis

  2007cited by this paper
• Mechanisms linking obesity with cardiovascular disease

  2006cited by this paper
• Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation

  2006cited by this paper
• Increased Infiltration of Macrophages in Omental Adipose Tissue Is Associated With Marked Hepatic Lesions in Morbid Human Obesity

  2006cited by this paper
• Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin

  2006cited by this paper
• Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss.

  2005cited by this paper
• Plasminogen activator inhibitor-1: a common denominator in obesity, diabetes and cardiovascular disease.

  2005cited by this paper
• Inflammatory Cytokines Interleukin-6 and Oncostatin M Induce Plasminogen Activator Inhibitor-1 in Human Adipose Tissue

  2005cited by this paper
• Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery.

  2005cited by this paper
• Changes in Leptin, Plasminogen Activator Factor and Oxidative Stress in Morbidly Obese Patients following Open and Laparoscopic Swedish Adjustable Gastric Banding

  2004cited by this paper
• Bariatric surgery: a systematic review and meta-analysis.

  2004cited by this paper
• Differences in Plasminogen Activator Inhibitor 1 in Subcutaneous Versus Omental Adipose Tissue in Non-Obese and Obese Subjects

  2003cited by this paper
• Stromal Cells Are the Main Plasminogen Activator Inhibitor‐1‐Producing Cells in Human Fat: Evidence of Differences Between Visceral and Subcutaneous Deposits

  2002cited by this paper
• Ultrasound Measurement of Visceral and Subcutaneous Fat in Morbidly Obese Patients Before and after Laparoscopic Adjustable Gastric Banding: Comparison with Computerized Tomography and with Anthropometric Measurements

  2002cited by this paper
• Results and complications after adjustable gastric banding in a series of 250 patients.

  2001cited by this paper
• Similar PAI-1 expression in visceral and subcutaneous fat of postmenopausal women.

  2001cited by this paper
• Effect of tumor necrosis factor alpha and transforming growth factor beta 1 on plasminogen activator inhibitor-1 secretion from subcutaneous and omental human fat cells in suspension culture.

  2000cited by this paper
• Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity.

  2000cited by this paper
• Regional Variation in Plasminogen Activator Inhibitor-1 Expression in Adipose Tissue from Obese Individuals

  2000cited by this paper
• Relationship between Visceral Fat and PAI-1 in Overweight Men and Women before and after Weight Loss

  1999cited by this paper
• Increased levels of tissue plasminogen activator antigen in essential hypertension. A population‐based study in Sweden

  1997cited by this paper
• Production of Plasminogen Activator Inhibitor 1 by Human Adipose Tissue: Possible Link Between Visceral Fat Accumulation and Vascular Disease

  1997cited by this paper
• Impaired fibrinolysis and insulin resistance in patients with hypertension.

  1996cited by this paper
• Enhanced levels of tissue-type plasminogen activator in borderline hypertension.

  1995cited by this paper
• Cell-associated plasminogen activation: regulation and physiological functions.

  1988cited by this paper
• The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Hormonal Control of Plasminogen Activator Inhibitor-1 Gene Expression and Production in Human Adipose Tissue: Stimulation by Glucocorticoids and

  year unknowncited by this paper

• Changes in fibrin clot properties in patients after Roux-en-Y gastric bypass surgery

  2024cites this paper
• Deciphering endocrine function of adipose tissue and its significant influences in obesity-related diseases caused by its dysfunction.

  2024cites this paper
• The Effect of Bariatric Surgery on PAI-1 Levels: A Systematic Review and Meta-analysis

  2024cites this paper
• Bariatric Surgery and Gut-Brain-Axis Driven Alterations in Cognition and Inflammation

  2023cites this paper
• Associations of adipokines with coronary heart disease in young and middle-aged people

  2023cites this paper
• The Roles and Associated Mechanisms of Adipokines in Development of Metabolic Syndrome

  2022cites this paper
• Androgen Effects on the Adrenergic System of the Vascular, Airway, and Cardiac Myocytes and Their Relevance in Pathological Processes

  2020cites this paper
• SERPINE-1 Gene Methylation and Protein as Molecular Predictors of Laparoscopic Sleeve Gastrectomy Outcome

  2020cites this paper
• Effect of Bariatric Surgery on the Circulating Level of Adiponectin, Chemerin, Plasminogen Activator Inhibitor-1, Leptin, Resistin, and Visfatin: A Systematic Review and Meta-Analysis

  2020cites this paper
• Effects of Obesity Surgery on Blood Coagulation and Fibrinolysis: A Literature Review

  2020cites this paper
• Interacting hepatic PAI-1/tPA gene regulatory pathways influence impaired fibrinolysis severity in obesity

  2020cites this paper
• Obesity affects brain structure and function- rescue by bariatric surgery?

  2019cites this paper
• The appropriate remodeling of extracellular matrix is the key molecular signature in subcutaneous adipose tissue following Roux‐en‐Y gastric bypass

  2019cites this paper
• Evaluation of all Types of Metabolic Bariatric Surgery and its Consequences: a Systematic Review and Meta-Analysis

  2018cites this paper
• Reduction of Premature Aging Markers After Gastric Bypass Surgery in Morbidly Obese Patients

  2018cites this paper
• Thromboelastography Values Remain Hypercoagulative 6 Months After Obesity Surgery: a Pilot Study

  2018cites this paper
• The effect of BMI on haemostasis: Implications for thrombosis in women's health.

  2017cites this paper
• Subcutaneous fat loss is greater than visceral fat loss with diet and exercise, weight-loss promoting drugs and bariatric surgery: a critical review and meta-analysis

  2017cites this paper
• Vascular risk in obesity: Facts, misconceptions and the unknown

  2017cites this paper
• Does bariatric surgery improve adipose tissue function?

  2016cites this paper
• Plasminogen activator inhibitor-1 in black South Africans, methodological and clinical considerations

  2016cites this paper
• Accumulation and Changes in Composition of Collagens in Subcutaneous Adipose Tissue After Bariatric Surgery.

  2016cites this paper
• The contribution of different adipose tissue depots to plasma plasminogen activator inhibitor-1 (PAI-1) levels.

  2016cites this paper
• Accumulation and Changes in Composition of Collagens in Subcutaneous Adipose Tissue Following Bariatric Surgery

  2016cites this paper
• Adipokines at the crossroad between obesity and cardiovascular disease

  2014cites this paper
• The Role of Plasminogen Activator Inhibitor-1 in the Metabolic Syndrome and Its Regulation

  2014cites this paper
• ‘Adiposopathy’ and cardiovascular disease: the benefits of bariatric surgery

  2013cites this paper
• Lipid profile changes after pronounced weight loss induced by bariatric surgery

  2012cites this paper
• Bariatric surgery for obese type 2 diabetes: do we have enough information?

  2012cites this paper
• Insulin resistance and bariatric surgery

  2012cites this paper
• Inflammation, obesity, and thrombosis.

  2012cites this paper
• pathophysiological relationship between obesity and chronic inflammation in the manifestation of metabolic dysfunctions and their inflammation‑mediating treatment options (Review)

  year unknowncites this paper